Chemical Structure and Properties

2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine belongs to the pyrazolo[1,5-a]pyrimidine family of fused bicyclic heterocycles, in which a five-membered pyrazole ring is annulated to a six-membered pyrimidine ring via a shared nitrogen atom at the 1,5-positions. The compound carries two distinct halogen substituents: a bromine atom at the C-2 position of the pyrazole ring and a chlorine atom at the C-7 position of the pyrimidine ring.

This dual-halogenation pattern confers differentiated reactivity at the two sites. The C–Br bond at C-2 is generally more reactive in palladium-catalyzed cross-coupling reactions (e.g., Suzuki–Miyaura, Buchwald–Hartwig), while the C–Cl bond at C-7 is well suited for nucleophilic aromatic substitution (S_NAr) with amines, alkoxides, and thiolates due to the electron-deficient character of the pyrimidine ring. This orthogonal reactivity makes the compound an exceptionally useful platform for sequential, chemoselective derivatization.

The aromatic bicyclic core is planar and electron-deficient, characteristics that facilitate interactions with biological targets such as protein kinase ATP-binding pockets. The compound is typically a solid at room temperature and should be stored in a cool, dry environment away from moisture and light to preserve chemical integrity.

Synthesis and Derivatization Strategies

The pyrazolo[1,5-a]pyrimidine core is typically constructed via cyclocondensation of 3-aminopyrazoles with 1,3-dicarbonyl equivalents or their synthetic surrogates. Subsequent halogenation at selected ring positions using reagents such as phosphoryl chloride (POCl₃) or N-bromosuccinimide (NBS) introduces the halogen handles necessary for downstream functionalization. 2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine (B190048) is provided as a ready-to-use starting material, eliminating these multi-step manipulations in the end-user's workflow.

Common derivatization routes from this scaffold include:

• Suzuki–Miyaura coupling at C-2: reaction of the aryl bromide with aryl- or heteroarylboronic acids under Pd(0) or Pd(II) catalysis to introduce (het)aryl groups.
• Buchwald–Hartwig amination at C-2: palladium-catalyzed C–N bond formation with primary or secondary amines.
• S_NAr at C-7: displacement of the chloride by amines under mild to moderate heating, often without metal catalysis, to install amino substituents critical for kinase pharmacophores.
• Sequential functionalization: selective S_NAr at C-7 first, followed by Pd-catalyzed coupling at C-2, or vice versa, enabling rapid construction of diverse analogue libraries.

These strategies make B190048 a highly efficient entry point into structurally diverse pyrazolopyrimidine chemical space.

Research Applications in Drug Discovery

The pyrazolo[1,5-a]pyrimidine scaffold is recognized in medicinal chemistry as a privileged structure for the design of kinase inhibitors. Its bicyclic aromatic system mimics the purine core of adenosine triphosphate (ATP), enabling productive binding within the ATP-binding cleft of protein kinases. Compounds based on this framework have been investigated as inhibitors of a broad range of therapeutically relevant kinases, including but not limited to cyclin-dependent kinases (CDKs), phosphoinositide 3-kinases (PI3Ks), and various oncology-relevant targets.

2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine (B190048) serves as a key intermediate in the construction of focused kinase inhibitor libraries. Researchers use it to efficiently introduce diversity at two independent positions, systematically exploring structure–activity relationships (SAR) around the core scaffold. The compound is also relevant in the synthesis of probe molecules for chemical biology studies aimed at target validation and pathway elucidation.

Beyond kinase biology, pyrazolopyrimidine derivatives have attracted interest in antiviral, anti-inflammatory, and CNS research programs, further broadening the utility of this building block for discovery chemistry teams.

Handling, Storage, and Safety Considerations

As with all halogenated organic reagents, 2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine should be handled with appropriate laboratory precautions. Users should consult the product Safety Data Sheet (SDS) supplied by Aladdin Scientific before use. Standard personal protective equipment (PPE) including nitrile gloves, laboratory coat, and safety eyewear is recommended.

The compound should be stored in a tightly sealed container under cool, dry conditions, away from direct light and sources of moisture. Exposure to moisture can potentially lead to slow hydrolysis of the C–Cl bond under harsh conditions; therefore, desiccated storage is advisable for long-term inventory. Compatibility with common laboratory solvents such as DMSO, DMF, dichloromethane, and THF is expected based on the compound's polarity profile, though users should verify solubility empirically for their specific applications.

Disposal of the compound and its derivatives should comply with local institutional and governmental regulations for halogenated organic waste. Contact Aladdin Scientific customer service for specific storage temperature recommendations and purity specifications for lot B190048.